A bitter pill to swallow: young people dislike tablets more than old
A bitter pill to swallow: young people dislike tablets more than old
Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusi... Read more
19 Oct 2014
•
2mins
Kemwell CEO says environmental efforts are worth the cost
Kemwell CEO says environmental efforts are worth the cost
Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.
26 Nov 2013
•
2mins
Similar Podcasts
The Drug Discovery World Podcast
PharmaTalkRadio
Pharma Intelligence Podcasts
The Bio Report
Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse
Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse
Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Un... Read more
22 Oct 2013
•
4mins
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits
In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity o... Read more
6 May 2013
•
3mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests
Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests
Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a ... Read more
21 Feb 2013
•
6mins
Is risk-based clinical trial monitoring too flexible for the regulators?
Is risk-based clinical trial monitoring too flexible for the regulators?
Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances fro... Read more
12 Nov 2012
•
4mins
Optimism is returning to the pharma fine chemicals sector, says analyst
Optimism is returning to the pharma fine chemicals sector, says analyst
The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trad... Read more
31 Oct 2012
•
4mins
Cobra Biologics talks recent fill finish acquisition and future growth plans
Cobra Biologics talks recent fill finish acquisition and future growth plans
CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
24 Oct 2012
•
3mins
Catalent says sharing with industry will not dull competetive edge
Catalent says sharing with industry will not dull competetive edge
Catalent says making its technology available to industry will not affect its competitive edge.
21 Oct 2012
•
4mins
Capsugel expands liquid fill capsule capabilities
Capsugel expands liquid fill capsule capabilities
Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.
16 Oct 2012
•
4mins
